A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome  Kelly Stamets,

Slides:



Advertisements
Similar presentations
Charles J. Glueck, M. D. , Joel Pranikoff, M. D. , Dawit Aregawi, M. D
Advertisements

J.C. Trussell, M.D., Allen R. Kunselman, M.A., Richard S. Legro, M.D. 
Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial  Åsa Lindholm,
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.
Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D. 
Leptin receptor variant in women with polycystic ovary syndrome
Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin.
Optimal euploid embryo transfer strategy, fresh versus frozen, after preimplantation genetic screening with next generation sequencing: a randomized controlled.
Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis  Konstantinos A. Toulis, M.D.,
The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study  Jeff G. Wang, M.D., Richard A. Anderson,
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis  Héctor F. Escobar-Morreale, M.D., Ph.D., Manuel Luque-Ramírez,
Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome 
Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,
Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters  Enrico Carmina, M.D., Francesco.
Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic.
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial 
Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome  Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature.
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels 
Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation  Martin Healey, M.D., W. Catarina Ang,
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral.
Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized.
Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study 
Adolescent Caucasian mothers have reduced adult hip bone density
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis  Shiqin Zhu, M.D., Bingqian Zhang, M.D.,
Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action  Vanita Aroda, M.D., Theodore.
Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced.
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study  Gwinnett Ladson, M.D., William C. Dodson,
Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women.
Feasibility of a brief, intensive weight loss intervention to improve reproductive outcomes in obese, subfertile women: a pilot study  Amy Rothberg, M.D.,
Increased secretion of amylin in women with polycystic ovary syndrome
Prevalence of polycystic ovary syndrome in adolescents
Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in.
Relationship between insulin resistance and gonadotropin dissociation in obese and nonobese women with polycystic ovary syndrome  Carlos Moran, M.D.,
Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.
Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome)  Louise A. Brinton, Ph.D., Kamran.
Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women.
Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment  Richard Fleming, Ph.D.,
Banu Ucar, M. D. , Volkan Noyan, M. D. , Osman Caglayan, M. D
Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial  Antoni J. Duleba, M.D.,
Diminished paternity and gonadal function with increasing obesity in men  Eric M. Pauli, M.D., Richard S. Legro, M.D., Laurence M. Demers, Ph.D., Allen.
Serum resistin levels in women with polycystic ovary syndrome
David Sokal, M. D. , Deborah Gates, Ramesh Amatya, Ph. D
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D. 
The Pregnancy in Polycystic Ovary Syndrome Study: baseline characteristics of the randomized cohort including racial effects  Richard S. Legro, M.D.,
Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study  Gwinnett Ladson,
Paolo Moghetti, M.D.  Fertility and Sterility 
Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D
High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model.
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy  Helena J. Teede, Ph.D., Caroline Meyer, Ph.D.,
Randomized controlled trial: effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization  Irene Moy, M.D., Magdy P. Milad, M.D.,
A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary.
Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test  Dimitrios Panidis, M.D., Ph.D., Dimitrios.
Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome  Basak Yildirim, M.D., Nuran Sabir,
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis 
Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3  Wendy Chang, M.D.,
Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity? 
Enrico Carmina, M.D., Rogerio A Lobo, M.D.  Fertility and Sterility 
Presentation transcript:

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome  Kelly Stamets, M.D., Denise S Taylor, M.S., FR.D., Allen Kunselman, M.A., Laurence M Demers, Ph.D., Christine L Pelkman, Ph.D., Richard S Legro, M.D.  Fertility and Sterility  Volume 81, Issue 3, Pages 630-637 (March 2004) DOI: 10.1016/j.fertnstert.2003.08.023

FIGURE 1 Flow chart of participant disposition in the study. Stamets. Hypocaloric diets in PCOS.Fertil Steril 2004. Fertility and Sterility 2004 81, 630-637DOI: (10.1016/j.fertnstert.2003.08.023)

FIGURE 2 Change in circulating levels of glucose and insulin during an oral glucose tolerance test over the course of the study. Glucose levels according to diet are in Panels A and B with combined data presented in Panel C. Insulin levels according to diet are found in Panels D and E with combined data presented in Panel F. No significant differences existed between treatment groups. Stamets. Hypocaloric diets in PCOS.Fertil Steril 2004. Fertility and Sterility 2004 81, 630-637DOI: (10.1016/j.fertnstert.2003.08.023)

FIGURE 3 Change in circulating levels of leptin during an oral glucose tolerance test over the course of the study. There are no significant differences between treatment groups; Panel A is the Hi-Protein diet group, Panel B the Hi-Carbohydrate group, and combined data are presented in Panel C. Stamets. Hypocaloric diets in PCOS.Fertil Steril 2004. Fertility and Sterility 2004 81, 630-637DOI: (10.1016/j.fertnstert.2003.08.023)